Grundinformationen
- Standard-SMILES
Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1- InChIKey
NQDJXKOVJZTUJA-UHFFFAOYSA-N- Summenformel
- C15H14N4O
- Durchschnittliche Molmasse
- 266,3 g/mol
- Monoisotopische Masse
- 266,11676108
Namen und Bezeichner
- Bevorzugter Name
- Nevirapine
- IUPAC
- 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
- Englischer Name
- Nevirapine
- Summenformel
- C15H14N4O
- Molmasse
- 266.3
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
129618-40-2- PubChem CID
- 4463
- DTXSID
DTXSID7031797- ChEMBL
CHEMBL57- ChEBI
CHEBI:63613- UNII
- 99DK7FVK1H
- EC Number
- 603-345-0
- Nikkaji
- J420.601K
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2
- Polarare Oberfläche (TPSA)
- 58,1 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 20
- Formalladung
- 0
- Komplexität
- 397
Physikochemische Eigenschaften
- Schmelzpunkt
- 247 °C · 247°C
- Siedepunkt
- 409.5 °C · 409.5°C (rough estimate)
- Dichte
- 1.13 · 1.1300 (rough estimate)
- Brechungsindex
- 1.62 · 1.6200 (estimate)
- Flammpunkt
- 9 ℃ · 9℃
- storage temp.
- 2 · 2-8°C
- Löslichkeit
- 22 mg/mL · DMSO: ≥22mg/mL
- Aggregatzustand
- powder
- pka
- 2.8 · 2.8(at 25℃)
- Farbe
- white to tan
- Wasserlöslichkeit
- 0.1 g/L · 0.1g/L(temperature not stated)
- Merck
- 14 · 14,6490
- BCS Class
- 2 · 2
- Major Application
- pharmaceutical (small molecule)
- InChI
- 1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)
- InChIKey
- NQDJXKOVJZTUJA-UHFFFAOYSA-N
- SMILES
- CC1=CC=NC2=C1NC(C(C=CC=N3)=C3N2C4CC4)=O
- CAS Datenbank
- 129618 · 129618-40-2(CAS DataBase Reference)
- EPA chemische Informationen
- 6 H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, · 6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- (129618-40-2)
Sicherheit und Regulatorisches
Sicherheitsdaten
- wgk
- 2
- ridadr
- UN1230 - class 3 - PG 2 - Methanol, solution
- hs_code
- 29339900
- RTECS-Nr.
- JM5562500
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 26-36-37/39
- Speicherklasse
- 11 - Combustible Solids
- Giftige Stoffe Daten
- 129618-40-2(Hazardous Substances Data)
Chemie und Industrie
Anwendungen
BeschreibungNevirapine and its analogues exhibit antiretroviral effect against azothymidine-resistant HIV strains. Nevirapine in combination with ZDV and ddI produced approximately 18% higher CD4 cell counts and a decrease in viral load compared with patients who took ZDV and ddI. Nevirapine is recommended with nucleosides for patients infected with HIV-1 who have experienced clinical or immunologic deterioration. The significant side effects of nevirapine are liver dysfunction and skin rashes.
VerwendenLabelled Nevirapine , a potent (IC50=84nM) and selective non-nucleoside inhibitor of HIV-1 reverse transcriptase. Antiviral.;Labeled Nevirapine, intended for use as an internal standard for the quantification of Nevirapine by GC- or LC-mass spectrometry.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter50 Anbieter
Ergänzende Hinweise
DefinitionChEBI: A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse tr nscriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…